Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Platinum-resistant Ovarian Cancer × niraparib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 57 Breast Neoplasms 19 Prostatic Neoplasms 15 Fallopian Tube Neoplasms 15 Neoplasms 13 Neoplasm Metastasis 9 Pancreatic Neoplasms 8 Glioblastoma 7 Endometrial Neoplasms 6 Triple Negative Breast Neoplasms 5 Lung Neoplasms 5 Glioma 4 Squamous Cell Carcinoma of Head and Neck 3 Small Cell Lung Carcinoma 3 Recurrence 3 Mesothelioma 3 Melanoma 3 Head and Neck Neoplasms 3 Cholangiocarcinoma 3 Carcinoma, Ovarian Epithelial 3 Uterine Cervical Neoplasms 2 Solid Tumor 2 Sarcoma 2 Prostatic Neoplasms, Castration-Resistant 2 Mesothelioma, Malignant 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Renal Cell 2 Brain Neoplasms 2 Biliary Tract Neoplasms 2

Interventions

anlotinib 2 niraparib 1 afuresertib 1 Paclitaxel 1 PHI-101 1 Gemcitabine 1 ALT-803 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04376073 2020-11-25

ANNIE

Sun Yat-sen University

Phase 2 Unknown

Platinum-resistant Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡